Stocktoria
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2009-05-01
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6,000 | $11,000 | $9,000 | $88,600 | $87,754 |
| Gross profit | $3,806 | $6,600 | $5,400 | $60,109 | $39,805 |
| R&D expense | $2.3M | $2.4M | $2.0M | $6.3M | $109,180 |
| SG&A expense | $3.8M | $3.2M | $3.6M | $3.9M | $3.0M |
| Operating income | -$6.1M | -$5.7M | -$5.6M | -$10.2M | -$3.1M |
| Interest expense | — | — | — | $0 | $4.3M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$6.0M | -$5.5M | -$5.3M | -$10.1M | $19.2M |
| EPS (diluted) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 |
| Operating cash flow | -$5.9M | -$5.3M | -$8.0M | -$7.8M | -$2.2M |
| Cash & equivalents | — | — | — | $8.3M | $10.7M |
| Inventory | $0 | $2,194 | $6,594 | $10,194 | $10,866 |
| Total assets | $7.8M | $6.7M | $10.7M | $19.2M | $11.3M |
| Total liabilities | $284,880 | $327,644 | $371,394 | $3.3M | $1.1M |
| Shareholders' equity | $7.5M | $6.3M | $10.3M | $15.9M | $10.2M |
Source: SEC EDGAR filings · CIK 0001187953 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.